Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cerenis Therapeutics, SA
Age
0–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female less than 75 years of age
Acute coronary syndrome (acute chest pain and a diagnosis of ST segment elevation myocardial infarction, non-ST elevation myocardial infarction or unstable angina)
Angiographic evidence of coronary artery disease with suitable "target" coronary artery for IVUS evaluation
You may not be if
Females of child-bearing potential
Weight \>120 kg
Angiographic evidence of \>50% stenosis of the left main artery
Uncontrolled diabetes (HbA1C\>10%)
Hypertriglyceridemia (\>500 mg/dL)
Congestive heart failure (NYHA class III or IV)
Ejection fraction \<35%
Uncontrolled hypertension (SBP \>180 mm Hg)
Known major hematologic, renal, hepatic, metabolic, gastrointestinal or endocrine dysfunction
Clareo Health | Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
